133 related articles for article (PubMed ID: 8518368)
1. Preparation of antigen-binding monomeric and half-monomeric fragments from human monoclonal IgM antibodies against colorectal cancer-associated antigens.
Ditzel H; Erb K; Leslie G; Jensenius JC
Hum Antibodies Hybridomas; 1993 Apr; 4(2):86-93. PubMed ID: 8518368
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical and biochemical characterizations of two monoclonal antibody-reacting antigens associated with human bladder carcinoma.
Zhang DS; Lin CW
Cancer Res; 1989 Dec; 49(23):6621-8. PubMed ID: 2819713
[TBL] [Abstract][Full Text] [Related]
3. Characterization of mucin antigens recognized by monoclonal antibodies raised against human colon cancer cells.
Fukui S; Horie T; Numata Y; Kitagawa H; Nakada H; Kawasaki T; Funakoshi I; Yamashina I
Cancer Res; 1991 Jan; 51(1):331-5. PubMed ID: 1988095
[TBL] [Abstract][Full Text] [Related]
4. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78.
Jakobsen CG; Rasmussen N; Laenkholm AV; Ditzel HJ
Cancer Res; 2007 Oct; 67(19):9507-17. PubMed ID: 17909061
[TBL] [Abstract][Full Text] [Related]
5. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
6. From IgG monoclonals to IgM-like molecules.
Ernst M; Meier D; Sonneborn HH
Hum Antibodies; 1999; 9(3):165-70. PubMed ID: 10690630
[TBL] [Abstract][Full Text] [Related]
7. Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM.
David K; Heiligtag S; Ollert MW; Teppke M; Vogel CW; Bredehorst R
Med Pediatr Oncol; 2001 Jan; 36(1):251-7. PubMed ID: 11464898
[TBL] [Abstract][Full Text] [Related]
8. [Purification of colorectal cancer-associated antigen by immuno-affinity chromatography].
Yang Y; Li Y; Wang XH; Shang P; Wang L; Qian AR; Yao XY; Chen ZN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):348-51. PubMed ID: 15193236
[TBL] [Abstract][Full Text] [Related]
9. Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients.
Brändlein S; Lorenz J; Ruoff N; Hensel F; Beyer I; Müller J; Neukam K; Illert B; Eck M; Müller-Hermelink HK; Vollmers HP
Hum Antibodies; 2002; 11(4):107-19. PubMed ID: 12775891
[TBL] [Abstract][Full Text] [Related]
10. [Preparation and characterization of human colon tumor-associated antigen and its clinical significance].
Liu XY; Yao XL; Song Y; Liu XY; Zhang P; Xu ZS; Song LH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):335-7. PubMed ID: 17428389
[TBL] [Abstract][Full Text] [Related]
11. [Expression and identification of phage display library for Fab fragments of colorectal cancer-related antibodies].
Sun X; Wu BP; Xiao B; Zhang ZS; Lai ZS
Di Yi Jun Yi Da Xue Xue Bao; 2002 Aug; 22(8):678-83. PubMed ID: 12376247
[TBL] [Abstract][Full Text] [Related]
12. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
Wong JY; Chu DZ; Williams LE; Yamauchi DM; Ikle DN; Kwok CS; Liu A; Wilczynski S; Colcher D; Yazaki PJ; Shively JE; Wu AM; Raubitschek AA
Clin Cancer Res; 2004 Aug; 10(15):5014-21. PubMed ID: 15297402
[TBL] [Abstract][Full Text] [Related]
13. Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33.
Ritter G; Cohen LS; Williams C; Richards EC; Old LJ; Welt S
Cancer Res; 2001 Sep; 61(18):6851-9. PubMed ID: 11559561
[TBL] [Abstract][Full Text] [Related]
14. Tumour localization and pharmacokinetics of iodine-125 human monoclonal IgM antibody (COU-1) and its monomeric and half-monomeric fragments analysed in nude mice grafted with human tumour.
Ditzel H; Rasmussen JW; Erb K; Jensenius JC
Eur J Nucl Med; 1992; 19(6):409-17. PubMed ID: 1618232
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitizer conjugation to the carcinoma 19-9 monoclonal antibody.
Borlinghaus KP; Fitzpatrick DA; Heindel ND; Mattis JA; Mease BA; Schray KJ; Shealy DJ; Walton HL; Woo DV
Cancer Res; 1987 Aug; 47(15):4071-5. PubMed ID: 3496956
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
17. Human monoclonal IgM DJ binds to ssDNA and human commensal bacteria.
Dimitrijević LA; Radulović MI; Cirić BP; Petrićević MM; Inić AB; Nikolić DN; Apostolski S
Hum Antibodies; 1999; 9(1):37-45. PubMed ID: 10331184
[TBL] [Abstract][Full Text] [Related]
18. Agglutinating activities of the subunits of one IgM cold agglutinin treated with various reducing agents.
Doinel C; Ropars C; Salmon C
Eur J Immunol; 1973 Sep; 3(9):563-8. PubMed ID: 4766956
[No Abstract] [Full Text] [Related]
19. Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design.
Deyev SM; Lebedenko EN
Bioessays; 2008 Sep; 30(9):904-18. PubMed ID: 18693269
[TBL] [Abstract][Full Text] [Related]
20. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens.
Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ
Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
